tm logo
JUVEDERM VOLBELLA
Live/Registered
REGISTERED AND RENEWED

on 27 Aug 2023

Last Applicant/ Owned by

1 N. Waukegan Road

North Chicago

IL

60064

Serial Number

85130270 filed on 15th Sep 2010

Registration Number

4380507 registered on 06th Aug 2013

in the Principal Register

Correspondent Address

Cheryl A. Withycombe

Cheryl A. Withycombe

Mail code: AND-250C

18655 Teller Avenue

IRVINE CA 92612

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

JUVEDERM VOLBELLA

Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles


First Use Date in General

19th Feb 2013

First Use Date in Commerce

19th Feb 2013

Specimens


JUVEDERM VOLBELLA specimenJUVEDERM VOLBELLA specimenJUVEDERM VOLBELLA specimenJUVEDERM VOLBELLA specimen

Mark Details


Serial Number

No 85130270

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ABVT116140

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Aug 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27th Aug 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Aug 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
27th Aug 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10th Feb 2023TEAS SECTION 8 & 9 RECEIVED
06th Aug 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03rd Dec 2020NOTICE OF SUIT
04th Apr 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04th Apr 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Apr 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED